Literature DB >> 12513691

Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation.

Julian C Knight1.   

Abstract

The role of host genetic variation in determining susceptibility to complex disease traits is the subject of much research effort, but it often remains unclear whether disease-associated genetic polymorphisms are themselves functionally relevant or acting only as markers within an extended haplotype. Experimental approaches to investigate the functional impact of polymorphisms in non-coding regulatory DNA sequences for gene expression are discussed, including the role of gel-shift assays, DNA footprinting and reporter gene analysis. The limitations of different experimental approaches are presented together with future prospects for in vivo analysis. The strategic application of these functional approaches is discussed and illustrated by analysis of the role of genetic variation in the tumour necrosis factor promoter region in determining susceptibility to severe malaria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12513691     DOI: 10.1042/CS20020304

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  26 in total

1.  BACE1 gene promoter single-nucleotide polymorphisms in Alzheimer's disease.

Authors:  Weihui Zhou; Fang Cai; Yu Li; George S Yang; Kathleen D O'Connor; Robert A Holt; Weihong Song
Journal:  J Mol Neurosci       Date:  2010-05-09       Impact factor: 3.444

2.  Identification of regulatory polymorphisms in the TNF-TNF receptor superfamily.

Authors:  Ju-Young Kim; Song-Mean Moon; Ha-Jung Ryu; Jae-Jung Kim; Hung-Tae Kim; Chan Park; Kuchan Kimm; Bermseok Oh; Jong-Keuk Lee
Journal:  Immunogenetics       Date:  2005-04-23       Impact factor: 2.846

3.  Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity.

Authors:  Andrea Baessler; Michael J Hasinoff; Marcus Fischer; Wibke Reinhard; Gabriele E Sonnenberg; Michael Olivier; Jeanette Erdmann; Heribert Schunkert; Angela Doering; Howard J Jacob; Anthony G Comuzzie; Ahmed H Kissebah; Anne E Kwitek
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

Review 4.  Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: current and developing technologies.

Authors:  Brian N Chorley; Xuting Wang; Michelle R Campbell; Gary S Pittman; Maher A Noureddine; Douglas A Bell
Journal:  Mutat Res       Date:  2008-05-04       Impact factor: 2.433

5.  Molecular prioritization strategies to identify functional genetic variants in the cardiovascular disease-associated expression QTL Vanin-1.

Authors:  Belinda J Kaskow; Luke A Diepeveen; J Michael Proffitt; Alexander J Rea; Daniela Ulgiati; John Blangero; Eric K Moses; Lawrence J Abraham
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

Review 6.  Regulatory SNPs and transcriptional factor binding sites in ADRBK1, AKT3, ATF3, DIO2, TBXA2R and VEGFA.

Authors:  Norman E Buroker
Journal:  Transcription       Date:  2014-10-31

7.  VEGFA rSNPs, transcriptional factor binding sites and human disease.

Authors:  Norman E Buroker
Journal:  J Physiol Sci       Date:  2013-10-06       Impact factor: 2.781

8.  ABCC8 Single Nucleotide Polymorphisms are Associated with Cerebral Edema in Severe TBI.

Authors:  Ruchira M Jha; Ava M Puccio; David O Okonkwo; Benjamin E Zusman; Seo-Young Park; Jessica Wallisch; Philip E Empey; Lori A Shutter; Robert S B Clark; Patrick M Kochanek; Yvette P Conley
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

9.  Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2.

Authors:  Wei Gu; You-an Shan; Jian Zhou; Dong-po Jiang; Lianyang Zhang; Ding-yuan Du; Zheng-guo Wang; Jian-xin Jiang
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

Review 10.  Bench-to-bedside review: Association of genetic variation with sepsis.

Authors:  Ainsley M Sutherland; Keith R Walley
Journal:  Crit Care       Date:  2009-04-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.